Variant report
Variant | nsv946507 |
---|---|
Chromosome Location | chr1:173109131-173118311 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:173115198-173115453 | A549 | lung: | n/a | chr1:173115366-173115377 |
2 | CEBPB | chr1:173115220-173115420 | Hela-S3 | cervix: | n/a | chr1:173115366-173115377 |
3 | CEBPB | chr1:173115248-173115535 | IMR90 | lung: | n/a | chr1:173115366-173115377 |
4 | CEBPB | chr1:173115212-173115446 | HepG2 | liver: | n/a | chr1:173115366-173115377 |
5 | CEBPB | chr1:173108942-173109291 | IMR90 | lung: | n/a | chr1:173109111-173109120 chr1:173109109-173109120 chr1:173109111-173109122 |
6 | CEBPB | chr1:173115282-173115405 | K562 | blood: | n/a | chr1:173115366-173115377 |
7 | CEBPB | chr1:173108970-173109259 | A549 | lung: | n/a | chr1:173109111-173109120 chr1:173109109-173109120 chr1:173109111-173109122 |
8 | CEBPB | chr1:173109014-173109181 | Hela-S3 | cervix: | n/a | chr1:173109111-173109120 chr1:173109109-173109120 chr1:173109111-173109122 |
9 | CEBPB | chr1:173108974-173109276 | HepG2 | liver: | n/a | chr1:173109111-173109120 chr1:173109109-173109120 chr1:173109111-173109122 |
10 | CTCF | chr1:173117780-173117930 | GM12873 | blood: | n/a | n/a |
11 | CTCF | chr1:173117640-173117790 | GM12875 | blood: | n/a | n/a |
12 | CTCF | chr1:173117760-173117910 | HCFaa | heart: | n/a | n/a |
13 | CTCF | chr1:173117680-173117830 | GM12868 | blood: | n/a | n/a |
14 | CTCF | chr1:173117740-173117890 | GM12872 | blood: | n/a | n/a |
15 | CTCF | chr1:173117660-173117810 | GM12864 | blood: | n/a | n/a |
16 | CTCF | chr1:173117580-173117730 | Hela-S3 | cervix: | n/a | n/a |
17 | JUND | chr1:173113458-173113763 | HepG2 | liver: | n/a | chr1:173113585-173113596 |
18 | POLR2A | chr1:173109926-173110104 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr1:173116665-173116701 | Gliobla | brain: | n/a | n/a |
20 | POLR2A | chr1:173111373-173111402 | Gliobla | brain: | n/a | n/a |
21 | POLR2A | chr1:173116720-173116855 | Gliobla | brain: | n/a | n/a |
22 | SETDB1 | chr1:173114896-173115439 | U2OS | brain: | n/a | n/a |
23 | STAT3 | chr1:173117121-173117136 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GOT2P2 | TF binding region |
ENSG00000224977 | chromatin interactions |
ENSG00000230849 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79435673 | chr1:173109169-173109170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533468274 | chr1:173109212-173109213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1234309 | chr1:173109224-173109225 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs12354046 | chr1:173109239-173109240 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187460876 | chr1:173109248-173109249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548891071 | chr1:173109254-173109255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192718815 | chr1:173109273-173109274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185423459 | chr1:173109284-173109285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549842666 | chr1:173109370-173109371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571215408 | chr1:173109381-173109382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142206554 | chr1:173109393-173109394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371765998 | chr1:173109394-173109395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543160081 | chr1:173109462-173109463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547390445 | chr1:173109464-173109465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189265620 | chr1:173109467-173109468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151200433 | chr1:173109473-173109474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556137031 | chr1:173109480-173109481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1234308 | chr1:173109507-173109508 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs538009706 | chr1:173109533-173109534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556725530 | chr1:173109564-173109565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs578008191 | chr1:173109576-173109577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545119852 | chr1:173109582-173109583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560092770 | chr1:173109586-173109587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572138766 | chr1:173109603-173109604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140257726 | chr1:173109639-173109640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544519263 | chr1:173109669-173109670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181977256 | chr1:173109740-173109741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549678014 | chr1:173109775-173109776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10912543 | chr1:173109778-173109779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184326224 | chr1:173109814-173109815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547549344 | chr1:173109847-173109848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554932605 | chr1:173109925-173109926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574470631 | chr1:173109955-173109956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189105377 | chr1:173109956-173109957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536301003 | chr1:173109968-173109969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10912544 | chr1:173110032-173110033 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs145137698 | chr1:173110063-173110064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147588110 | chr1:173110073-173110074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34698489 | chr1:173110090-173110091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572035219 | chr1:173110181-173110182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142003320 | chr1:173110246-173110247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs578145372 | chr1:173110313-173110314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560288709 | chr1:173110317-173110318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186579203 | chr1:173110347-173110348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553886352 | chr1:173110360-173110361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375879345 | chr1:173110410-173110411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150727409 | chr1:173110415-173110416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572102448 | chr1:173110469-173110470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542565263 | chr1:173110472-173110473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561352658 | chr1:173110495-173110496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:173104400-173119200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:173107200-173110200 | Weak transcription | HSMMtube | muscle |
3 | chr1:173109000-173110800 | Enhancers | Dnd41 | blood |
4 | chr1:173109600-173110000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr1:173110200-173110400 | Enhancers | HSMMtube | muscle |
6 | chr1:173113800-173116600 | ZNF genes & repeats | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr1:173114000-173114400 | Weak transcription | HSMMtube | muscle |
8 | chr1:173115200-173116000 | Weak transcription | HSMMtube | muscle |
9 | chr1:173116000-173118400 | Strong transcription | HSMMtube | muscle |
10 | chr1:173116200-173120400 | Weak transcription | Right Ventricle | heart |
11 | chr1:173116400-173118000 | ZNF genes & repeats | HSMM | muscle |
12 | chr1:173117000-173117600 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr1:173117400-173117800 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr1:173117400-173118000 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr1:173117600-173118000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr1:173117600-173119400 | Enhancers | Placenta Amnion | Placenta Amnion |
17 | chr1:173117600-173119800 | Enhancers | Placenta | Placenta |
18 | chr1:173117600-173122000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr1:173117800-173120000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr1:173118000-173118600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
21 | chr1:173118000-173119200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
22 | chr1:173118000-173119200 | Weak transcription | HSMM | muscle |
23 | chr1:173118200-173122800 | Weak transcription | Primary hematopoietic stem cells | blood |